Maze Therapeutics, Inc. (MAZE) Stock Analysis
Free AI-powered analysis and research for Maze Therapeutics, Inc. stock
Sector: Healthcare
Full MAZE report
Maze Therapeutics, Inc. (MAZE) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze MAZE Now βπ° Latest Update
Wall Street Analysts Predict a 93.92% Upside in Maze Therapeutics, Inc. (MAZE): Here's What You Should Know
Wed, November 4, 2026 at 1:55 PM UTC 3 min read
Maze Therapeutics, Inc. (MAZE) has seen a 22% increase in its stock price over the past month, closing at $32.25. Wall Street analysts project a mean price target of $62.54, suggesting a potential upside of 93.9%, with estimates ranging from $46.00 to $110.00. Despite the optimistic outlook, the article cautions investors to approach price targets with skepticism, emphasizing the importance of earnings estimate revisions, which have shown positive trends for MAZE.